Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Bladder cancer
by Highest Patent Value in the Sweden in 2020

The Bladder cancer top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Bladder cancer Key Players in the Sweden. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
#
Company Name
Region
Tech Topics
Total
1
Cantargia AB
Receptor,Medical equipment,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 5.12 M
2
Active Biotech AB
Medicine,Immunotherapy,Molecule,
...[+2]
Avg patent value: 2.65 M
3
Fujirebio Diagnostics AB
Monoclonal antibody,Medicine,Reagent
Avg patent value: 2.26 M
4
Isofol Medical AB
Medicine,Clinical trial,Colorectal cancer,
...[+2]
Avg patent value: 176,333
5
Atlas Antibodies AB
Antibody,Medicine,Health care,
...[+2]
Avg patent value: 150,000
6
Elypta AB
Liquid biopsy,Health care,Software,
...[+2]
Avg patent value: 40,000
7
Medivir AB
Cancer,Oncology,Medicine,
...[+2]
Avg patent value: 0
8
Oncopeptides AB
Clinical trial,Multiple myeloma,Medicine,
...[+2]
Avg patent value: 0
9
Belina Pharma AB
Breast cancer,Oncology,Drug
Avg patent value: 0
10
Hakmed AB
Avg patent value: 0
Page generation time: Jun 27 2025